COVID-19 in hospitalised patients in Spain: a cohort study in Madrid
스페인 입원 환자의 COVID-19: 마드리드 코호트 연구
Article
[키워드] 95% CI
Admission
Alanine
alanine aminotransferase
Analysis
Antiviral
ARDS
C-reactive protein
calculated
cardiovascular disease
Clinical characteristics
Cohort
cohort study
Combination
Corticosteroids
Costs
COVID-19
creatine
creatine kinase
death
determine
diabetes
Diabetes Mellitus
died
elevated
elevated lactate dehydrogenase
Factor
followed by
hazard ratio
hospital
hospitalisation
hospitalised patient
Hydroxychloroquine
hypertension
hypoxaemia
ICU
interferon beta
Interferon beta-1b
Lactate
lactate dehydrogenase
logistic regression model
Lopinavir
Lopinavir/ritonavir
lymphocytopenia
male
median age
Mortality
Multivariate analysis
multivariate Cox model
obesity
Older age
on admission
outcome
Patient
patients
Prevalence
receiving
required
risk factor
Risk factors
Ritonavir
SARS-CoV-2
Spain
Spanish
therapy
Tocilizumab
Total
Treatment
was used
were used
[DOI] 10.1016/j.ijantimicag.2020.106249 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ijantimicag.2020.106249 PMC 바로가기 [Article Type] Article